The Daily Mail
November 19, 2014
by Madlen Davies for MailOnline
Rise in ADHD cases is ‘due to marketing, not medicine’: Study blames increase on drug companies, pushy support groups, and people self-diagnosing online
- ADHD is ‘an economic and cultural plague than a medical one’
- Diagnosis and treatment rates are soaring compared to five years ago
- Experts said five key trends have contributed to ADHD growth
- Pharmaceutical companies lobby for drug treatment for the condition
- Support groups often work with pharmaceutical companies
- Treatment of ADHD with talking therapies has eroded in favour of drugs
- U.S. guidelines with low thresholds for ADHD diagnosis has been adopted
- Web use makes self-diagnosis easy and people pester doctor for drugs
The global surge in ADHD diagnosis has more to do with marketing than medicine, according to experts.
Diagnosis rates and prescriptions of stimulant drugs are soaring compared with five years ago, but experts say ADHD is ‘more of an economic and cultural plague than a medical one’.After examining the growth of ADHA in the UK, Germany, France, Italy and Brazil, they concluded there are five trends which contribute to its growth.
They blame the rise on lobbying from drug companies, who have spurred some countries to relax the restrictions put on stimulants like Ritalin, the most well-known drug used to treat ADHD.Psychoanalytic treatment of the condition, usually with talking therapies, is slowly being eroded in favour of treating the problem with drugs, they said.More psychologists and psychiatrists are now adopting the American Diagnostic and Statistical Manual (DSM) standards, which are broader and have a lower threshold for diagnosing ADHD, they added.